IL-2 (Aldesleukin): Clinical Trials

1 trial of IL-2 (Aldesleukin), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow IL-2 (Aldesleukin): new trials by email Literature Review of IL-2 (Aldesleukin) trials Research Report on IL-2 (Aldesleukin)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
IL-2 (Aldesleukin), Semaglutide Plus IL-2, Placebo - Alzheimer Dementia (AD)
Phase 1 / Phase 2RecruitingThe Methodist Hospital Research Institute302026-09-012026-11-06

Conditions studied

Alzheimer Disease (1)  ·  Inflammation (1)

Sponsors

The Methodist Hospital Research Institute (1)

Countries

United States (1)